|
1
|
de Groot PM, Wu CC, Carter BW and Munden
RF: The epidemiology of lung cancer. Transl Lung Cancer Res.
7:220–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barta JA, Powell CA and Wisnivesky JP:
Global epidemiology of lung cancer. Ann Glob Health. 85:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y
and Lu Y: ACT001, a novel PAI-1 inhibitor, exerts synergistic
effects in combination with cisplatin by inhibiting PI3K/AKT
pathway in glioma. Cell Death Dis. 10:7572019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhong W, Yang W, Qin Y, Gu W, Xue Y, Tang
Y, Xu H, Wang H, Zhang C, Wang C, et al: 6-Gingerol stabilized the
p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel
normalization and suppresses tumor progression. J Exp Clin Cancer
Res. 38:2852019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen D, Ma W, Ke Z and Xie F: CircRNA
hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung
cancer progression. Cell Cycle. 17:2080–2090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer.
25:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang MM, Mai ZT, Wan SZ, Chi YM, Zhang X,
Sun BH and Di QG: Microarray profiles reveal that circular RNA
hsa_circ_0007385 functions as an oncogene in non-small cell lung
cancer tumorigenesis. J Cancer Res Clin Oncol. 144:667–674. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S
and Yuan H: Microarray profile of circular RNAs identifies
hsa_circ_0014130 as a new circular RNA biomarker in non-small cell
lung cancer. Sci Rep. 8:28782018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao JT, Zhao SH, Liu QP, Lv MQ, Zhou DX,
Liao ZJ and Nan KJ: Over-expression of CircRNA_100876 in non-small
cell lung cancer and its prognostic value. Pathol Res Pract.
213:453–456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei CY, Zhu MX, Lu NH, Liu JQ, Yang YW,
Zhang Y, Shi YD, Feng ZH, Li JX, Qi FZ and Gu JY: Circular RNA
circ_0020710 drives tumor progression and immune evasion by
regulating the miR-370-3p/CXCL12 axis in melanoma. Mol Cancer.
19:842020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambros V: MicroRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xi X, Chu Y, Liu N, Wang Q, Yin Z, Lu Y
and Chen Y: Joint bioinformatics analysis of underlying potential
functions of hsa-let-7b-5p and core genes in human glioma. J Transl
Med. 17:1292019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Moor CH, Meijer H and Lissenden S:
Mechanisms of translational control by the 3′ UTR in development
and differentiation. Semin Cell Dev Biol. 16:49–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waldman SA and Terzic A: MicroRNA
signatures as diagnostic and therapeutic targets. Clin Chem.
54:943–944. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sicklick JK, Li YX, Jayaraman A, Kannangai
R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS
and Diehl AM: Dysregulation of the Hedgehog pathway in human
hepatocarcinogenesis. Carcinogenesis. 27:748–757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patil MA, Zhang J, Ho C, Cheung ST, Fan ST
and Chen X: Hedgehog signaling in human hepatocellular carcinoma.
Cancer Biol Ther. 5:111–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang S, He J, Zhang X, Bian Y, Yang L,
Xie G, Zhang K, Tang W, Stelter AA, Wang Q, et al: Activation of
the hedgehog pathway in human hepatocellular carcinomas.
Carcinogenesis. 27:1334–1340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang YA, Chen YF, Bao Y, Mahara S, Yatim
SMJM, Oguz G, Lee PL, Feng M, Cai Y, Tan EY, et al: Hypoxic tumor
microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote
chemoresistance in colorectal cancer. Proc Natl Acad Sci USA.
115:E5990–E5999. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia L, Bouamar H, Gu X, Zeballos C, Qin T,
Wang B, Zhou Y, Wang Y, Yang J, Zhu H, et al: Gli2 mediates the
development of castration-resistant prostate cancer. Int J Oncol.
57:100–112. 2020.PubMed/NCBI
|
|
27
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koul R, Rathod S, Dubey A, Bashir B and
Chowdhury A: Comparison of 7th and 8th editions of the UICC/AJCC
TNM staging for non-small cell lung cancer in a non-metastatic
North American cohort undergoing primary radiation treatment. Lung
Cancer. 123:116–120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu W, Bi ZY, Chen ZL, Liu C, Li LL, Zhang
F, Zhou Q, Zhu W, Song YY, Zhan BT, et al: Emerging landscape of
circular RNAs in lung cancer. Cancer Lett. 427:18–27. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang X, Zhang W and Shao Z: Prognostic
and diagnostic significance of circRNAs expression in lung cancer.
J Cell Physiol. 234:18459–18465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma Y, Zhang X, Wang YZ, Tian H and Xu S:
Research progress of circular RNAs in lung cancer. Cancer Biol
Ther. 20:123–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di X, Jin X, Li R, Zhao M and Wang K:
CircRNAs and lung cancer: Biomarkers and master regulators. Life
Sci. 220:177–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang C, Tan S, Li J, Liu WR, Peng Y and Li
W: CircRNAs in lung cancer-Biogenesis, function and clinical
implication. Cancer Lett. 492:106–115. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Braicu C, Zimta AA, Harangus A, Iurca I,
Irimie A, Coza O and Berindan-Neagoe I: The function of non-coding
RNAs in lung cancer tumorigenesis. Cancers (Basel). 11:6052019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan
X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential
novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao J, Li L, Wang Q, Han H, Zhan Q and Xu
M: CircRNA expression profile in early-stage lung adenocarcinoma
patients. Cell Physiol Biochem. 44:2138–2146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Schooneveld E, Wildiers H, Vergote I,
Vermeulen PB, Dirix LY and Van Laere SJ: Dysregulation of microRNAs
in breast cancer and their potential role as prognostic and
predictive biomarkers in patient management. Breast Cancer Res.
17:212015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhong W, Hou H, Liu T, Su S, Xi X, Liao Y,
Xie R, Jin G, Liu X, Zhu L, et al: Cartilage oligomeric matrix
protein promotes epithelial-mesenchymal transition by interacting
with transgelin in colorectal cancer. Theranostics. 10:8790–8806.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chung SJ, Nagaraju GP, Nagalingam A,
Muniraj N, Kuppusamy P, Walker A, Woo J, Győrffy B, Gabrielson E,
Saxena NK and Sharma D: ADIPOQ/adiponectin induces cytotoxic
autophagy in breast cancer cells through STK11/LKB1-mediated
activation of the AMPK-ULK1 axis. Autophagy. 13:1386–1403. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng SM, Chang YC, Liu CY, Lee JY, Chan
HH, Kuo CW, Lin KY, Tsai SL, Chen SH, Li CF, et al: YM155
down-regulates survivin and XIAP, modulates autophagy and induces
autophagy-dependent DNA damage in breast cancer cells. Br J
Pharmacol. 172:214–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhu B, Chen H, Zhang X, Pan Y, Jing R,
Shen L, Wang X, Ju S, Jin C and Cong H: Serum miR-30d as a novel
biomarker for multiple myeloma and its antitumor role in U266 cells
through the targeting of the MTDH/PI3K/Akt signaling pathway. Int J
Oncol. 53:2131–2144. 2018.PubMed/NCBI
|
|
44
|
Xu X, Zong K, Wang X, Dou D, Lv P, Zhang Z
and Li H: MiR-30d suppresses proliferation and invasiveness of
pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts
poor outcome. Cell Death Dis. 12:3502021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ye C, Yu X, Liu X, Dai M and Zhang B:
MiR-30d inhibits cell biological progression of Ewing's sarcoma by
suppressing the MEK/ERK and PI3K/Akt pathways in vitro. Oncol Lett.
15:4390–4396. 2018.PubMed/NCBI
|
|
46
|
Bhateja P, Cherian M, Majumder S and
Ramaswamy B: The Hedgehog signaling pathway: A viable target in
breast cancer? Cancers (Basel). 11:11262019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He Y, Huang H, Jin L, Zhang F, Zeng M, Wei
L, Tang S, Chen D and Wang W: CircZNF609 enhances hepatocellular
carcinoma cell proliferation, metastasis, and stemness by
activating the Hedgehog pathway through the regulation of
miR-15a-5p/15b-5p and GLI2 expressions. Cell Death Dis. 11:3582020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Thiyagarajan S, Bhatia N, Reagan-Shaw S,
Cozma D, Thomas-Tikhonenko A, Ahmad N and Spiegelman VS: Role of
GLI2 transcription factor in growth and tumorigenicity of prostate
cells. Cancer Res. 67:10642–10646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Regl G, Neill GW, Eichberger T, Kasper M,
Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM and Aberger
F: Human GLI2 and GLI1 are part of a positive feedback mechanism in
basal cell carcinoma. Oncogene. 21:5529–5539. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hinz M, Krappmann D, Eichten A, Heder A,
Scheidereit C and Strauss M: NF-kappaB function in growth control:
Regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
Mol Cell Biol. 19:2690–2698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Saha A, Halder S, Upadhyay SK, Lu J, Kumar
P, Murakami M, Cai Q and Robertson ES: Epstein-Barr virus nuclear
antigen 3C facilitates G1-S transition by stabilizing and enhancing
the function of cyclin D1. PLoS Pathog. 7:e10012752011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rutter M, Wang J, Huang Z, Kuliszewski M
and Post M: Gli2 influences proliferation in the developing lung
through regulation of cyclin expression. Am J Respir Cell Mol Biol.
42:615–625. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang D, Liu J, Wang Y, Chen J and Chen T:
shRNA-mediated silencing of Gli2 gene inhibits proliferation and
sensitizes human hepatocellular carcinoma cells towards
TRAIL-induced apoptosis. J Cell Biochem. 112:3140–3150. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Singh R, Letai A and Sarosiek K:
Regulation of apoptosis in health and disease: The balancing act of
BCL-2 family proteins. Nat Rev Mol Cell Biol. 20:175–193. 2019.
View Article : Google Scholar : PubMed/NCBI
|
